Sean Wieland
Stock Analyst at Piper Sandler
(1.82)
# 3,287
Out of 5,182 analysts
31
Total ratings
45.45%
Success rate
1.71%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $37.37 | +47.18% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $23.84 | +51.01% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $5.88 | +1,940.82% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $30.56 | -80.37% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $24.01 | +83.26% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $162.28 | +42.35% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $5.75 | +4,960.87% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $37.37
Upside: +47.18%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $23.84
Upside: +51.01%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $5.88
Upside: +1,940.82%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $30.56
Upside: -80.37%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $24.01
Upside: +83.26%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $162.28
Upside: +42.35%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $5.75
Upside: +4,960.87%